Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Pay $587M for Convertible Notes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that its offer to purchase any and all outstanding 2.5 percent convertible senior notes due 2023 has expired, with 95.6 percent of the outstanding notes validly tendered.

The firm also said that it settled its previously announced redemption of all of its outstanding 6.75 percent Senior Subordinated Notes due 2014. It paid an aggregate of approximately $317.0 million to redeem the entire $300,000,000 principal amount of Senior Subordinated Notes outstanding, at a redemption price of 103.375 percent of the principal amount of the notes redeemed.

The firm said that it expects to settle the offers today and pay an aggregate of around $586.6 million to purchase all of the convertible notes that were validly tendered and not withdrawn.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.